Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Dec 1;60(12):5724-5733.
doi: 10.1093/rheumatology/keab238.

Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma

Suzanne C Li  1 , Gloria C Higgins  2 , Mallory Chen  3 , Kathryn S Torok  4 , C Egla Rabinovich  5 , Katie Stewart  6 , Ronald M Laxer  7 , Elena Pope  8 , Kathleen A Haines  9 , Marilynn Punaro  6 , Kathleen M O'Neil  10 ; Childhood Arthritis and Rheumatology Research Alliance Localized Scleroderma Clinical and Ultrasound Study group
Affiliations
Observational Study

Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma

Suzanne C Li et al. Rheumatology (Oxford). .

Abstract

Objective: The aim of this study was to evaluate factors associated with extracutaneous involvement (ECI) in juvenile localized scleroderma (jLS).

Methods: A prospective, multicentre, 6-month observational study was performed. The data collected included disease features, global assessments, and subject symptoms. Bivariate and linear multilevel regression analyses were performed.

Results: A total of 86 jLS subjects (80% female, 80% Caucasian), median age of disease onset 7.7 years, were evaluated. Most had linear scleroderma or mixed morphea. Of the 86 subjects, 49 (57%) had 125 extracutaneous problems {median 2 [interquartile range (IQR) 1, 3] per subject} from nine organ systems. Most of these subjects had multiple musculoskeletal problems. ECI was associated with more extensive cutaneous involvement, higher number of symptoms, family history of autoimmunity, and ANA and RF positivity. Subjects with ECI had higher scores for physician global assessment of damage (PGA-D), and parental global assessment of disease impact, but not baseline physician global assessment of disease activity (PGA-A). Although subjects with ECI received more MTX and glucocorticoid treatment, they had a slower reduction in PGA-A scores and symptoms over time, suggesting a poorer response to treatment. In logistic regression modelling, female sex had the largest effect on parental impact scores.

Conclusion: ECI occurred in the majority of subjects with jLS, and was associated with more medication use, longer treatment duration, higher PGA-D scores, and higher parental assessment of disease impact. Our findings suggest that jLS subjects with ECI have greater overall disease burden, both cutaneous and extracutaneous, and poorer response to treatment. More study of the treatment needs of this population is warranted.

Keywords: damage; extracutaneous manifestation; linear scleroderma; morbidity; morphea; symptoms; treatment response.

PubMed Disclaimer

Publication types